Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2021-07-27

Original market date: See footnote 1

1998-06-02

Lot number: See footnote 2

20-0173

Expiry date: See footnote 2

2022-03-31

Product name:

TERAZOSIN-5

DIN:

02237478 Electronic product monograph is not available

Company:

PRO DOC LIMITEE
2925 Boulevard Industriel
Laval
Quebec
Canada H7L 3W9

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

24:20.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

G04CA03 TERAZOSIN

Active ingredient group (AIG) number:See footnote5

0136978003

List of active ingredient(s)
Active ingredient(s) Strength
TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG
Version 4.0.2
Date modified: